title: Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women.
abstract: Vitamin D supplements have been used to prevent fractures. The effect may be mediated through increased bone mass, but also through reduced falling propensity. The aim of this study was to evaluate the association between 25-hydroxy vitamin D levels (25OHD), fall-associated variables (including tests of functional performance), and fracture in ambulatory women. At baseline 25OHD was measured in 986 women. Fall-associated variables were investigated at baseline. Fractures were recorded during a 3-year follow-up. Four percent of the women had 25OHD levels below 20 ng/ml (50 nmol/l), and 26% had 25OHD levels below 30 ng/ml (75 nmol/l). 25OHD correlated with gait speed (r =0.17, P <0.001), the Romberg balance test (r =0.14, P <0.001), self-estimated activity level (r =0.15, P <0.001), and thigh muscle strength (r =0.08, P =0.02). During the 3-year follow-up, 119 out of the 986 women sustained at least one fracture. The Cox proportional hazard ratio (HR) (95% confidence interval) for sustaining a fracture during the follow-up was 2.04 (1.04-4.04) for the group of women with 25OHD below 20 ng/ml, in which 9 out of 43 women sustained a fracture. Thirty-two of the 256 women with 25OHD levels below 30 ng/ml sustained a fracture during the follow-up, with a non-significant HR of 1.07 (1.07-1.61). This cohort of elderly, ambulatory women had a high mean 25OHD. A low 25OHD was associated with inferior physical activity level, gait speed and balance. A 25OHD level below 30 ng/ml was not associated with an increased risk of fractures in this study. However, a subgroup of women with 25OHD levels below 20 ng/ml had a tendency to an increased risk of fractures, which may be associated with an inferior physical activity and postural stability.
authors.affiliation: Department of Orthopedics, Malmö University Hospital, Lund University, Malmö, Sweden. paul.gerdhem@skane.se
authors.forename: P
authors.initials: P
authors.lastname: Gerdhem
authors.forename: K A M
authors.initials: KA
authors.lastname: Ringsberg
authors.forename: K J
authors.initials: KJ
authors.lastname: Obrant
authors.forename: K
authors.initials: K
authors.lastname: Akesson
mesh_terms: D000058:Accidental Falls; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D002112:Calcifediol / Q000097:blood*; D015331:Cohort Studies; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology*; D006801:Humans; D009043:Motor Activity; D018482:Muscle, Skeletal / Q000502:physiology*; D011237:Predictive Value of Tests; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D014807:Vitamin D; C104450:25-hydroxyvitamin D; D002112:Calcifediol
references.citation: Age Ageing. 1985 Mar;14(2):76-84
references.pmid: 4003187
references.citation: Cochrane Database Syst Rev. 2001;(1):CD000227
references.pmid: 11279685
references.citation: Osteoporos Int. 2003 May;14(3):208-12
references.pmid: 12730785
references.citation: Endocr Rev. 2001 Aug;22(4):477-501
references.pmid: 11493580
references.citation: Osteoporos Int. 1995;5(4):239-46
references.pmid: 7492862
references.citation: J Am Geriatr Soc. 1999 Oct;47(10):1195-201
references.pmid: 10522952
references.citation: J Bone Miner Res. 2002 May;17(5):891-7
references.pmid: 12009020
references.citation: Lancet. 2002 Jun 1;359(9321):1929-36
references.pmid: 12057569
references.citation: Arch Phys Med Rehabil. 1999 Jan;80(1):54-8
references.pmid: 9915372
references.citation: J Bone Miner Res. 2000 Jun;15(6):1113-8
references.pmid: 10841179
references.citation: Calcif Tissue Int. 2000 Jun;66(6):419-24
references.pmid: 10821877
references.citation: Aging (Milano). 1999 Jun;11(3):200-7
references.pmid: 10476316
references.citation: Am J Clin Nutr. 2003 Feb;77(2):504-11
references.pmid: 12540414
references.citation: Osteoporos Int. 2002 Mar;13(3):187-94
references.pmid: 11991436
references.citation: J Bone Miner Res. 2003 Feb;18(2):343-51
references.pmid: 12568412
references.citation: Osteoporos Int. 1999;9(5):394-7
references.pmid: 10550457
references.citation: J Am Geriatr Soc. 1999 Feb;47(2):220-6
references.pmid: 9988294
references.citation: Lancet. 1998 Mar 14;351(9105):805-6
references.pmid: 9519960
references.citation: Cochrane Database Syst Rev. 2003;(4):CD000340
references.pmid: 14583918
references.citation: Gerontology. 2003 Mar-Apr;49(2):93-116
references.pmid: 12574670
references.citation: Clin Lab. 2001;47(7-8):357-65
references.pmid: 11499797
references.citation: J Am Coll Nutr. 2003 Apr;22(2):142-6
references.pmid: 12672710
references.citation: Lancet. 1976 Mar 20;1(7960):626-9
references.pmid: 55903
references.citation: J Clin Endocrinol Metab. 2004 Jul;89(7):3152-7
references.pmid: 15240586
references.citation: N Engl J Med. 1997 Sep 4;337(10):670-6
references.pmid: 9278463
references.citation: N Engl J Med. 1995 Mar 23;332(12):767-73
references.pmid: 7862179
references.citation: J Am Geriatr Soc. 1995 Nov;43(11):1269-71
references.pmid: 7594162
references.citation: Am J Med. 1992 Jul;93(1):69-77
references.pmid: 1385673
references.citation: J Bone Miner Res. 1988 Aug;3(4):369-73
references.pmid: 3265576
references.citation: Gerontology. 2003 May-Jun;49(3):168-72
references.pmid: 12679607
references.citation: N Engl J Med. 1998 Sep 10;339(11):733-8
references.pmid: 9731089
references.citation: Age Ageing. 1999 May;28(3):289-93
references.pmid: 10475866
references.citation: J Clin Endocrinol Metab. 2004 Jul;89(7):3149-51
references.pmid: 15240585
references.citation: Osteoporos Int. 1997;7(5):439-43
references.pmid: 9425501
references.citation: BMJ. 2003 Mar 1;326(7387):469
references.pmid: 12609940
references.citation: Osteoporos Int. 2003 Apr;14 (2):152-9
references.pmid: 12730772
references.citation: J Clin Endocrinol Metab. 1988 May;66(5):927-33
references.pmid: 3360900
references.citation: JAMA. 2004 Apr 28;291(16):1999-2006
references.pmid: 15113819